BETs that cover the spread from acquired to heritable heart failure
- 1 September 2020
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (9) , 4536-4539
Abstract
Heart failure (HF) with reduced contractile function is a common and lethal syndrome in which the heart cannot pump blood to adequately meet bodily demands, resulting in high mortality despite the current standard of care. In modern societies, the most common drivers of HF are ischemic heart disease and hypertension. However, in a substantial subset of cases, patients present with dilated and poorly contracting hearts without evidence of common inciting stressors, a syndrome called dilated cardiomyopathy (DCM). Genome sequencing has identified a host of deleterious germline variants in key cardiomyocyte genes as causes of heritable DCM, including mutations in LMNA, which encodes the nuclear lamina-associated protein lamin A/C. In this issue of the JCI, Auguste et al. generate a mouse model of DCM in which they delete Lmna in cardiomyocytes and discover that bromodomain and extraterminal (BET) protein activation is a druggable epigenetic mechanism of disease pathogenesis in this heritable HF syndrome.Keywords
This publication has 18 references indexed in Scilit:
- BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient miceJournal of Clinical Investigation, 2020
- Reevaluating the Genetic Contribution of Monogenic Dilated CardiomyopathyCirculation, 2020
- Lamin A/C Cardiomyopathy: Implications for TreatmentCurrent Cardiology Reports, 2019
- Epigenetic therapies in heart failureJournal of Molecular and Cellular Cardiology, 2019
- BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failureScience Translational Medicine, 2017
- NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and AtherogenesisMolecular Cell, 2014
- BET acetyl-lysine binding proteins control pathological cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2013
- BET Bromodomains Mediate Transcriptional Pause Release in Heart FailureCell, 2013
- Suppression of inflammation by a synthetic histone mimicNature, 2010
- Selective inhibition of BET bromodomainsNature, 2010